New York State Common Retirement Fund Kronos Bio, Inc. Transaction History

New York State Common Retirement Fund

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$1.24 - $1.92 $34,348 - $53,184	-27,700 Reduced 98.7%	366 $1,000
Q3 2022 Nov 08, 2022	BUY	$3.35 - $5.55 $381 - $632	114 Added 0.41%	28,066 $94,000
Q2 2022 Aug 04, 2022	SELL	$3.12 - $7.52 $277 - $669	-89 Reduced 0.32%	27,952 $102,000
Q1 2022 May 05, 2022	BUY	$6.26 - $14.42 $81 - $187	13 Added 0.05%	28,041 $203,000
Q4 2021 Feb 02, 2022	SELL	$11.35 - $21.18 $737 - $1,376	-65 Reduced 0.23%	28,028 $381,000
Q3 2021 Nov 02, 2021	SELL	$18.17 - $24.7 $96,973 - $131,823	-5,337 Reduced 15.96%	28,093 $589,000
Q2 2021 Aug 02, 2021	BUY	$20.08 - $29.02 $406,218 - $587,074	20,230 Added 153.26%	33,430 $801,000
Q1 2021 May 11, 2021	BUY	$27.0 - $32.48 $48,600 - $58,463	1,800 Added 15.79%	13,200 $386,000
Q4 2020 Feb 08, 2021	BUY	$26.68 - $38.23 $304,152 - $435,821	11,400 New	11,400 $341,000

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $53.9M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.